CBIO vs RGNX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
CBIO
RGNX
Investment Advisor Scores
RGNX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CBIO | RGNX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 0 | Tie |
| PEG Ratio | 0 | 0.26 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.0% | 405.7% | RGNX |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.3/100 | 43.6/100 | CBIO |
| Profit Margin | 0.0% | -112.6% | CBIO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CBIO
MarkdownPrice below a falling SMA50 (slope -5.8%), weak momentum, RSI 39
RGNX
MarkdownPrice below a falling SMA50 (slope -11.9%), weak momentum, RSI 36
Fundamentals Snapshot
| Metric | CBIO | RGNX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -4.9 | -2.3 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 4.1% |
| Gross Margin | 1.0% | -0.4% |
| Operating Margin | -14.3% | 0.3% |
| EPS | -7.62 | -3.78 |
| Dividend Yield | — | — |